StockData
NovoCure Ltd logo

NovoCure Ltd (NVCR) shareholders

NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3031% below fair value
$11.14−0.16 (-1.42%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
88.5%
103M of 117M shares
Institutional holders
216
32 new, 35 sold out
Net institutional buying
5M
In Q2 2026
Insider trades, 12 months
0 buys · 28 sales
Net sold $3.40M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Abigail P. Johnson
Joint filing with FMR LLC (14.94%)
15,962,76514.94%13G (passive) amendmentFeb 9, 2024
Soleus Capital, LLC
Joint filing with Soleus Capital Master Fund, L.P. (9.10%), Soleus Capital Group, LLC (9.10%) and 3 more
10,492,3919.10%13G (passive) amendmentMar 31, 2026
Soleus Capital Management, L.P.
Joint filing with Soleus Capital Master Fund, L.P. (8.10%), Soleus Capital, LLC (8.10%) and 3 more
9,425,7768.10%13G (passive) amendmentSep 30, 2026
BlackRock, Inc.9,083,6208.30%13G (passive) amendmentMar 31, 2025
Soleus Capital Group, LLC
Joint filing with Soleus Capital Master Fund, L.P. (7.60%), Soleus Capital, LLC (7.60%) and 3 more
8,530,6657.60%13G (passive) amendmentDec 31, 2025
Soleus GP, LLC
Joint filing with Soleus Capital Master Fund, L.P. (6.20%), Soleus Capital, LLC (6.20%) and 3 more
6,904,3026.20%13G (passive) amendmentJun 30, 2025
Vanguard Portfolio Management6,339,9945.57%13G (passive)Mar 31, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of NVCRValueChange% of portfolio
FMR LLC17,373,07814.86%$263.20M+303,9290.01%
BlackRock, Inc.13,413,69911.47%$203.22M+219,9340.00%
Soleus Capital Management, L.P.9,913,4018.48%$150.19M−578,9905.18%
Vanguard Portfolio Management LLC6,272,4905.36%$95.03M+20,7890.00%
Vanguard Capital Management LLC4,903,6334.19%$74.29M+221,5690.00%
Morgan Stanley4,522,3893.87%$68.51M−19,1370.00%
State Street Corp2,866,5462.45%$43.43M+304,7290.00%
Geode Capital Management, LLC2,798,3512.39%$42.40M+286,6440.00%
Wells Fargo & Company/Mn2,528,0932.16%$38.30M−423,1440.01%
Quantinno Capital Management LP2,223,4551.90%$33.69M−263,9210.04%
Renaissance Technologies LLC1,951,9111.67%$29.57M+400,3570.04%
JPMorgan Chase & Co1,671,0821.43%$25.94M+740,9160.00%
Healthcare Of Ontario Pension Plan Trust Fund1,385,6001.19%$20.99M+659,2000.03%
Palo Alto Investors LP1,280,4391.10%$19.40M–2.68%
Nuveen, LLC1,232,0871.05%$18.67M+249,7340.00%
Jacobs Levy Equity Management, Inc1,164,0721.00%$17.64M−167,4200.06%
Empowered Funds, LLC1,154,4310.99%$17.49MNew0.09%
Aqr Capital Management LLC1,102,1310.94%$16.65M+827,1990.01%
Dimensional Fund Advisors LP1,091,9460.93%$16.55M+131,8900.00%
D. E. Shaw & Co., Inc.1,022,4800.87%$15.49M+375,4180.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026216103M88.5%32 / 9063 / 3512M7M
Q1 202622499M84.6%39 / 7675 / 5023M9M
Q4 202523996M81.8%44 / 10061 / 4016M11M
Q3 202524592M78.7%48 / 8480 / 4513M15M
Q2 202524394M80.8%46 / 8670 / 2913M14M
Q1 202522895M81.4%39 / 7177 / 4812M8M
Q4 202423992M78.4%54 / 6677 / 3710M12M
Q3 202422593M79.8%25 / 6180 / 3323M11M
Q2 202423793M79.6%47 / 7770 / 4515M14M
Q1 202423893M79.4%44 / 8163 / 2511M10M
Q4 202322092M78.8%45 / 8455 / 5015M15M
Q3 202322792M78.8%43 / 7364 / 8213M11M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
William F. DoyleExecutive Chairman, Director681,1670.58%Mar 5, 2026
Mukund ParavasthuChief Operating Officer69,7530.06%Nov 12, 2026
Christoph BrackmannChief Financial Officer175,4990.15%Nov 12, 2026
Michal Nath PuriChief Human Resources Officer202,5670.17%Nov 4, 2026
Arye Barak BenGeneral Counsel243,7520.21%Jul 1, 2026
Frank X. LeonardChief Executive Officer461,4250.39%Jul 1, 2026
Nicolas LeupinFormer Chief Medical Officer102,9790.09%Mar 5, 2026
Uri WeinbergChf Medical and Innovation Ofr267,1900.23%Mar 5, 2026
Ashley CordovaFormer Chief Executive Officer422,5700.36%Mar 5, 2026
Asaf DanzigerDirector416,7420.36%Jul 1, 2026
Martin J. MaddenDirector30,6680.03%Jun 5, 2026
Timothy J. ScannellDirector25,8980.02%Jun 5, 2026
W. Anthony VernonDirector209,2670.18%Jun 5, 2026
Gabriel LeungDirector101,1090.09%Jun 5, 2026
Jeryl L. HillemanDirector25,4710.02%Jun 5, 2026
David HungDirector32,0750.03%Jun 5, 2026
Kristin StaffordDirector22,9340.02%Jun 5, 2026
Allyson J. OceanDirector22,9340.02%Jun 5, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Christoph Brackmann
Chief Financial Officer
Nov 9, 2026Sale−7,343$12.86$94.45K175,499
Mukund Paravasthu
Chief Operating Officer
Nov 9, 2026Sale−3,079$12.86$39.60K69,753
Michal Nath Puri
Chief Human Resources Officer
Nov 2, 2026Sale−660$13.24$8.74K202,567
Asaf Danziger
Director
Jun 30, 2026Award+268$11.15$2.99K416,742
Arye Barak Ben
General Counsel
Jun 30, 2026Award+1,299$11.15$14.48K243,752
Michal Nath Puri
Chief Human Resources Officer
Jun 30, 2026Award+1,905$11.15$21.24K203,227
Frank X. Leonard
Chief Executive Officer
Jun 30, 2026Award+1,905$11.15$21.24K461,425
Frank X. Leonard
Chief Executive Officer
Jun 4, 2026Sale−34,273$17.93$614.51K459,520
W. Anthony Vernon
Director
Jun 3, 2026Award+11,610––209,267
Kristin Stafford
Director
Jun 3, 2026Award+11,610––22,934
David Hung
Director
Jun 3, 2026Award+11,610––32,075
Allyson J. Ocean
Director
Jun 3, 2026Award+11,610––22,934
Martin J. Madden
Director
Jun 3, 2026Award+11,610––30,284
Timothy J. Scannell
Director
Jun 3, 2026Award+11,610––25,898
Jeryl L. Hilleman
Director
Jun 3, 2026Award+11,610––25,471
Gabriel Leung
Director
Jun 3, 2026Award+11,610––101,109
Allyson J. Ocean
Director
Jun 2, 2026Sale−2,945$15.77$46.44K11,324
W. Anthony Vernon
Director
Jun 2, 2026Sale−2,945$15.77$46.44K197,657
Kristin Stafford
Director
Jun 2, 2026Sale−2,945$15.77$46.44K11,324
David Hung
Director
Jun 2, 2026Sale−2,945$15.77$46.44K20,465
Gabriel Leung
Director
Jun 2, 2026Sale−2,945$15.77$46.44K89,499
Timothy J. Scannell
Director
Jun 2, 2026Sale−2,945$15.77$46.44K14,288
Jeryl L. Hilleman
Director
Jun 2, 2026Sale−2,945$15.77$46.44K13,861
W. Anthony Vernon
Director
Apr 28, 2026Option exercise+21,500$11.39$244.89K200,602
Mukund Paravasthu
Chief Operating Officer
Mar 5, 2026Sale−43,246$13.77$595.50K72,832
Frank X. Leonard
Chief Executive Officer
Mar 4, 2026Sale−5,607$13.31$74.63K493,793
Mukund Paravasthu
Chief Operating Officer
Mar 4, 2026Sale−5,377$13.31$71.57K116,078
Ashley Cordova
Former Chief Executive Officer
Mar 4, 2026Tax withholding−17,638$13.30$234.59K422,570
Christoph Brackmann
Chief Financial Officer
Mar 4, 2026Sale−6,412$13.31$85.34K182,842
Michal Nath Puri
Chief Human Resources Officer
Mar 4, 2026Sale−1,100$13.31$14.64K201,322
Nicolas Leupin
Former Chief Medical Officer
Mar 4, 2026Sale−1,100$13.31$14.64K102,979
Uri Weinberg
Chf Medical and Innovation Ofr
Mar 4, 2026Sale−6,412$13.31$85.34K267,190
Arye Barak Ben
General Counsel
Mar 3, 2026Award+50,125––242,453
Frank X. Leonard
Chief Executive Officer
Mar 3, 2026Award+150,000––499,400
Mukund Paravasthu
Chief Operating Officer
Mar 3, 2026Award+45,112––121,455
William F. Doyle
Executive Chairman, Director
Mar 3, 2026Award+200,000––200,000
William F. Doyle
Executive Chairman, Director
Mar 3, 2026Sale−50,557$12.79$646.62K349,727
William F. Doyle
Executive Chairman, Director
Mar 3, 2026Sale−21,330$13.43$286.46K328,397
William F. Doyle
Executive Chairman, Director
Mar 3, 2026Award+200,284––400,284
Christoph Brackmann
Chief Financial Officer
Mar 3, 2026Award+55,137––189,254
Michal Nath Puri
Chief Human Resources Officer
Mar 3, 2026Award+40,100––202,422
Uri Weinberg
Chf Medical and Innovation Ofr
Mar 3, 2026Award+50,125––273,602
Uri Weinberg
Chf Medical and Innovation Ofr
Mar 2, 2026Sale−3,272$13.33$43.62K223,477
Mukund Paravasthu
Chief Operating Officer
Mar 2, 2026Sale−408$13.49$5.50K76,343
Ashley Cordova
Former Chief Executive Officer
Mar 2, 2026Tax withholding−7,228$13.67$98.81K440,208
Ashley Cordova
Former Chief Executive Officer
Mar 2, 2026Tax withholding−2,410$13.67$32.94K447,436
Frank X. Leonard
Chief Executive Officer
Mar 2, 2026Sale−7,232$13.49$97.56K349,400
Uri Weinberg
Chf Medical and Innovation Ofr
Feb 28, 2026Award+12,992––226,749
Ashley Cordova
Former Chief Executive Officer
Feb 28, 2026Award+23,818––449,846
Frank X. Leonard
Chief Executive Officer
Feb 28, 2026Award+18,621––356,632
Arye Barak Ben
General Counsel
Feb 28, 2026Award+17,755––192,328
Uri Weinberg
Chf Medical and Innovation Ofr
Feb 27, 2026Sale−7,461$13.84$103.26K213,757
Mukund Paravasthu
Chief Operating Officer
Feb 27, 2026Sale−1,555$13.66$21.24K76,751
Ashley Cordova
Former Chief Executive Officer
Feb 27, 2026Tax withholding−11,541$13.75$158.69K426,028
Nicolas Leupin
Former Chief Medical Officer
Feb 27, 2026Sale−1,029$13.66$14.06K104,079
Frank X. Leonard
Chief Executive Officer
Feb 27, 2026Sale−9,734$13.66$132.97K338,011
Michal Nath Puri
Chief Human Resources Officer
Feb 27, 2026Sale−1,441$13.66$19.68K162,322
Mukund Paravasthu
Chief Operating Officer
Jan 11, 2026Tax withholding−2,133$14.35$30.61K78,306
Arye Barak Ben
General Counsel
Dec 31, 2025Award+108$10.99$1.19K174,573
Michal Nath Puri
Chief Human Resources Officer
Dec 31, 2025Award+1$10.99$11163,763

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
11.39%
13M shares short
Days to cover
6.0
At 2M shares a day
Change since last report
+0.7%
From 13M shares
Short volume, 20 days
51.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of NovoCure's stock actually held short. Settlement fails (shares not delivered on time) peaked at 22,282 shares on Aug 27, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Christoph Brackmann
Officer
Nov 9, 20267,343$94.45KNov 9, 2026Restricted Stock
Nicolas Leupin
Officer
Jul 23, 202639,088$608.60KJul 23, 2026Exercise of Stock Options
Francis Leonard
Officer
Jun 4, 202634,273$614.63KJun 4, 2026Restricted Stock
Mukund Paravasthu
Officer
Mar 5, 202643,246$595.68KMar 5, 2026Restricted stock vesting under a registered plan
Christoph Brackmann
Officer
Mar 4, 20266,412$85.31KMar 4, 2026Restricted stock
Uri Weinberg
Officer
Mar 4, 20266,412$85.31KMar 4, 2026Restricted stock
Mukund Paravasthu
Officer
Mar 4, 20265,377$71.54KMar 4, 2026Restricted Stock
Francis Leonard
Officer
Mar 4, 20265,607$74.60KMar 4, 2026Restricted Stock
William F. Doyle
Officer, Director
Mar 3, 202671,887$932.88KMar 3, 2026Performance Shares
Francis Leonard
Officer
Mar 2, 20267,232$97.58KMar 2, 2026Performance Shares
Uri Weinberg
Officer
Mar 2, 20263,272$43.61KMar 2, 2026Restricted Stock
Francis Leonard
Officer
Feb 27, 20269,734$133.00KFeb 27, 2026Restricted Stock
Uri Weinberg
Officer
Feb 27, 20267,461$103.26KFeb 27, 2026Restricted Stock
Francis Leonard
Officer
Jun 2, 202530,196$577.05KJun 2, 2025Restricted Stock Units
Mukund Paravasthu
Officer
May 5, 2025592$10.60KMay 5, 2025Restricted Stock

See a number that looks wrong?